Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 31, 2001

View Archived Issues

Scotia Moves Into Administration Following Rejection Of Foscan

Mouse Embryo Development Hinges On Sperm Entry Point

ExonHit Sets Up Shop In U.S., Expands Into Heart Diseases

Eurogene Acquires Quattrogene, Phase II Product In Stock Deal

UK Approves Human Embryo Cloning; Ethics Debate Coming

French Researchers Show Value Of Stem Cells In Hair Follicles

New UK BIA Chairman Pushes Industry To Go On Offensive

Draft Report Sparks Debate Among European Ministers

German Government Commits DM1.5B To Biotech Research

Other News To Note

IDgene Raises $7.6M Privately For Genetic Variability Program

PPL Gets £42M Commitment For AAT Manufacturing Facility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...